Your Roadmap for Long-Term Monitoring and Success
At a Glance
With prediabetes, annual blood-sugar review is the usual minimum, but testing every 3 to 6 months may be appropriate when results are near the diabetes range or health changes. Monitoring cholesterol, blood pressure, and selected kidney or liver markers supports broader risk reduction.
Managing prediabetes is a long-term commitment, but it does not require a constant state of medical emergency. Instead, the goal is surveillance: a structured, proactive schedule of check-ins designed to catch changes early and ensure your protective habits are working [1]. Think of your annual checkup not just as a “test,” but as a comprehensive review of your metabolic health.
Your Annual Glycemic Review
The cornerstone of prediabetes monitoring is an annual assessment of your blood sugar [1]. Current guidelines recommend that every adult with prediabetes should have their diabetes status re-evaluated at least once every 12 months [1].
While an annual check is the standard, your doctor might suggest testing every 3 to 6 months based on clinical judgment if [2][3]:
- Your numbers are at the high end of the prediabetes range (e.g., an HbA1c of 6.2% to 6.4%) [4].
- You have multiple abnormal results (e.g., both high fasting glucose and a high A1c) [3].
- You are starting a new medication like metformin [5].
- You have had a significant change in weight or health status [6].
The Comprehensive Lab Checklist
Because prediabetes affects more than just your sugar, your individualized monitoring plan should include more than just an A1c test. At your yearly visit, ensure the following are reviewed:
- Lipid Panel: A check of your LDL (“bad”) cholesterol, HDL (“good”) cholesterol, and triglycerides [7]. Managing these is often more important for preventing heart disease than managing sugar alone [8].
- Blood Pressure: Hypertension is present in over 36% of adults with prediabetes [7]. Keeping your blood pressure in a healthy range is vital for protecting your heart and kidneys [9].
- Kidney Health Markers: A blood test for eGFR (to see how well your kidneys filter) and a urine test for uACR (to check for protein leakage) may be performed if you have risk factors like high blood pressure or carry extra weight around your middle [10][11].
- Liver Enzymes: While standard tests like GGT or ALT alone cannot definitively rule in or rule out MASLD, your clinician may use them alongside other factors to decide if further assessment is needed to screen for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), commonly known as fatty liver, which can drive insulin resistance [11].
Beyond the Labs: The Psychological Aspect
Living with a “pre-” diagnosis can carry a unique psychological burden. It can feel like living with a “ticking clock” or a sense of failure if numbers don’t improve quickly [12][13].
It is important to understand that reversion (returning to normal blood sugar) is not the only definition of success [14]. If your numbers stay stable and do not progress to type 2 diabetes, your lifestyle changes and monitoring are working [1]. Many people have a biological “high-risk phenotype” where their bodies struggle to return to normal glucose levels even with significant effort; in these cases, stability is a major victory [15].
Creating Your Care Plan
To make the most of your monitoring, consider these strategies for your next visit:
- Request a Care Plan: Ask your doctor to document your specific monitoring schedule in your medical record [1].
- Coordinate with a DPP: If you are in a Diabetes Prevention Program (DPP), share your lab results with your lifestyle coach to help tailor your goals [2].
- Address Barriers: If stress, sleep apnea, or cost are making it hard to stick to your plan, bring these up. These “lifestyle disruptors” are just as medically relevant as your A1c [16].
Monitoring is not about waiting for something to go wrong; it is about gathering the data you need to stay in control of your health.
Common questions in this guide
How often should I have an A1c test if I have prediabetes?
What health checks should be included in yearly prediabetes monitoring?
Does stable prediabetes mean my prevention plan is working?
Should I ask about heart, kidney, or fatty liver risks with prediabetes?
What should I do if stress, poor sleep, or cost makes lifestyle changes difficult?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since my last result was in the prediabetes range, should we schedule my next HbA1c test for 6 months or 12 months from now?
- 2.Can we review my 10-year cardiovascular risk score together to see if I need more aggressive blood pressure or cholesterol management?
- 3.Based on my weight and blood pressure, should we add a urine albumin-to-creatinine ratio (uACR) test to my annual labs to check my kidney health?
- 4.Are there other 'silent' conditions we should screen for annually, such as fatty liver or sleep apnea, that might be affecting my blood sugar?
- 5.If my numbers stay the same despite my lifestyle efforts, does that mean my current plan is working, or do we need to intensify my treatment?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
A position statement on screening and management of prediabetes in adults in primary care in Australia.
Bell K, Shaw JE, Maple-Brown L, et al.
Diabetes research and clinical practice 2020; (164()):108188 doi:10.1016/j.diabres.2020.108188.
PMID: 32360708 - 2
Diagnosis and Management of Prediabetes: A Review.
Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S
JAMA 2023; (329(14)):1206-1216 doi:10.1001/jama.2023.4063.
PMID: 37039787 - 3
Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study.
Tura A, Grespan E, Göbl CS, et al.
Diabetes 2021; (70(9)):2092-2106 doi:10.2337/db21-0227.
PMID: 34233929 - 4
Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes.
Yamagata F, Ogata R, Koda Y, et al.
Journal of diabetes investigation 2024; (15(2)):177-185 doi:10.1111/jdi.14092.
PMID: 37817552 - 5
Effectiveness of an Incentives-Enhanced Stepped Care Intervention Program in Diabetes Prevention in a Multiethnic Asian Prediabetes Cohort: Results From the Pre-DICTED Randomized Controlled Trial.
Bee YM, Awasthi N, Gandhi M, et al.
Diabetes care 2025; (48(11)):1951-1959 doi:10.2337/dc25-1555.
PMID: 40970814 - 6
Developing risk models for predicting incidence of diabetes and prediabetes in the first-degree relatives of Iranian patients with type 2 diabetes and comparison with the finnish diabetes risk score.
Shahraki PK, Feizi A, Aminorroaya S, et al.
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2025; (30()):17 doi:10.4103/jrms.jrms_139_23.
PMID: 40302997 - 7
Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
Ali MK, Bullard KM, Saydah S, et al.
The lancet. Diabetes & endocrinology 2018; (6(5)):392-403 doi:10.1016/S2213-8587(18)30027-5.
PMID: 29500121 - 8
Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.
Welsh C, Welsh P, Celis-Morales CA, et al.
Diabetes care 2020; (43(2)):440-445 doi:10.2337/dc19-1683.
PMID: 31852727 - 9
Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in Black Adults: The Jackson Heart Study.
Hubbard D, Colantonio LD, Tanner RM, et al.
Diabetes care 2019; (42(12)):2322-2329 doi:10.2337/dc19-1074.
PMID: 31591089 - 10
Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort.
Izarra A, Bermúdez-López M, Valdivielso JM, et al.
Diabetes, obesity & metabolism 2026; (28(5)):3777-3787 doi:10.1111/dom.70560.
PMID: 41705635 - 11
Prevalence and factors linked to renal involvement in prediabetes patients across Europe in the ePREDICE trial.
Mas-Fontao S, Civantos E, Boukichou N, et al.
Scientific reports 2024; (14(1)):30336 doi:10.1038/s41598-024-79842-w.
PMID: 39638835 - 12
Perspectives on Prediabetes and Aging.
Al-Sofiani ME, Asiri A, Alajmi S, Alkeridy W
Endocrinology and metabolism clinics of North America 2023; (52(2)):377-388 doi:10.1016/j.ecl.2022.10.011.
PMID: 36948785 - 13
Uncertainty and certainty: perceptions and experiences of prediabetes in New Zealand primary care – a qualitative study.
McKinlay E, Hilder J, Hood F, et al.
Journal of primary health care 2022; (14(2)):138-145 doi:10.1071/HC21066.
PMID: 35771692 - 14
A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes.
Stefan N, Staiger H, Wagner R, et al.
Diabetologia 2015; (58(12)):2877-84 doi:10.1007/s00125-015-3760-z.
PMID: 26404062 - 15
Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.
Zhu R, Jalo E, Silvestre MP, et al.
Diabetes care 2022; (45(11)):2698-2708 doi:10.2337/dc22-0549.
PMID: 35696263 - 16
Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle Medicine.
Rosenfeld RM, Grega ML, Karlsen MC, et al.
American journal of lifestyle medicine 2025; (19(2 Suppl)):10S-131S doi:10.1177/15598276251325488.
PMID: 40546761
This page explains long-term prediabetes monitoring for informational purposes only and does not constitute medical advice. Your clinician should choose the testing schedule and lab checks that fit your health history.
Get notified when new evidence is published on prediabetes syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.